Drug Promotion on Social Media By Consumers: Can It Be Regulated?

Kim Kardashian recently used social media to promote the use of a prescription drug. In her Instagram post, Ms. Kardashian told her followers that a physician recommended use of the drug Diclegis to alleviate her symptoms of morning sickness. Ms. Kardashian is not the only public figure to recently deal with morning sickness as the Duchess of Cambridge also dealt with this issue, reported here. Having experienced positive results following the use of this drug, Ms. Kardashian posted her intent to pair with the
Continue reading...

FDA Cracks Down on Promotional Claims Made on Facebook

In this day and age nearly everyone has a Facebook page, including companies which often use Facebook pages to promote their products and services. Given that Facebook is quite an informal marketing medium, companies may not always scrutinize everything they post as highly as they would more organized or targeted media. But that doesn’t mean the Food and Drug Administration isn’t scrutinizing every wall post and status update. On March 12, 2014, the FDA posted an untitled letter to a Switzerland-based international drug maker, noting…
Continue reading...

Food & Drug Administration – Only 113 Characters Left In the Tweet

The FDA is on its way to regulating social media and its use by pharmaceutical companies.  By July 2014, the FDA must publish its guidelines for social media use. The FDA is faced with issuing guidelines on the appropriateness of tweeting.  A 140 character tweet is likely not long enough to include all of the necessary information such as risks and side effects.  Thomas Abrams, director of the FDA’s Office of Prescription Drug Promotion supports pharmaceutical companies promoting their products on Twitter if they can…
Continue reading...